Company intelligence / Profile preview

Sinopharm Ruifulai Pharmaceutical

Tianjin, Tianjin, China
Ownership
Private
Employees
~400
Development stage
Other
01

Overview

Sinopharm Ruifulai Pharmaceutical is a specialized pharmaceutical manufacturing subsidiary of Sinopharm Modern Pharmaceutical, part of the state-owned China National Pharmaceutical Group (Sinopharm). Based in Tianjin, the company focuses on the production of high-quality finished dosage forms, including tablets, capsules, and granules. Its therapeutic focus primarily covers cardiovascular, anti-infective, and respiratory medicine. The company's product portfolio features widely used generic medications such as amlodipine besylate and azithromycin, produced under strict GMP compliance. As a key production base within the Sinopharm network, it supports both the domestic Chinese healthcare system and international export markets. The facility is recognized as a high-tech enterprise and maintains a strong reputation for quality control and manufacturing efficiency.

Therapeutic areas
Infectious DiseasesCardiovascular
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

1 asset

HKG-319

Unknown

Beyond the preview

Go deeper on Sinopharm Ruifulai Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinopharm Ruifulai Pharmaceutical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call